These findings are consistent with our earlier studies in which we found that the extent of APOMAB binding in vitro to dead cancer cells correlated with the extent of APOMAB co-localization with foci of the double strand DNA break (DSB) marker, γ-H2AX [23]. This evidence concerns the gene H2AX and cancer.